- Home
- / Chimera Bioengineering
Chimera Bioengineering
Chimera Bioengineering Summary
Company Summary
- Overview
- Chimera Bioengineering is a company developing gene therapeutics to treat cancer. Its antigen receptor T-cells (CAR-Ts) are reprogrammed immune cells to circumvent immune-evasion.
- Type
- Private
- Status
- Active
- Founded
- 2015
- HQ
- South San Francisco, CA, US | view all locations
- Website
- http://www.chimera.bio/
- Cybersecurity rating
Table of Contents
Key People
Gus Zeiner, Co-Founder, Chief Science Officer
Andrew Kumamoto, General Counsel, VP of Intellectual Property
LocationsView all
1 location detected
South San Francisco, CA HQ
United States
329 Oyster Point Blvd 3rd Floor